The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Effect of cyclosporine on blood pressure
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The primary objective of this systematic review is to measure the blood pressure raising effect of cyclosporine in comparison to placebo in randomized trials. We are not assessing adverse cardiovascular events as we expect the trials to be too short.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“No increase in blood pressure with aspirin”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [35]
In the citing paper
“NSAIDs can antagonize the effects of RAAS-inhibitors and beta blockers”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [35]
In the citing paper
“3/1 mm Hg increase with nonselective NSAIDs”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [35]
In the citing paper
“No difference or an increase of up to 3/1 mm Hg with celecoxib”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [35]
In the citing paper
“Increased odds ratio of 3.19 of hypertension with tricyclic antidepressant”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [35]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin A
Elliott, J. F., Lin, Y., Mizel, S. B., Bleackley, R. C., Harnish, D. G., & Paetkau, V. (1984) · Science · doi:10.1126/science.6334364 · Cited by 395
Hypertension in cyclosporine-treated renal transplant recipients is sodium dependent
Curtis, J. J., Luke, R. G., Jones, P., & Diethelm, A. G. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80331-0 · Cited by 240
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis
Tugwell, P., Bombardier, C., Tugwell, P., Gent, M., BENNETT, K. J., Roberts, R. S., LUDWIN, D., Bensen, W., Carette, S., Chalmers, A., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)92630-z · Cited by 233
INDUCTION OF CONTRACTION IN ISOLATED RAT AORTA BY CYCLOSPORINE
XUE, H., Bukoski, R. D., McCarron, D. A., & Bennett, W. M. (1987) · Transplantation · doi:10.1097/00007890-198705000-00022 · Cited by 108
Cyclosporine-Associated Hypertension
Porter, G. A., Jr. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.2.280 · Cited by 93
Effect of isradipine on cyclosporin A-related hypertension.
van den Dorpel, Zietse, R., Ijzermans, J. N. M., Schalekamp, M. A., & Weimar, W. (1994) · PubMed · Cited by 11
Cyclosporine-associated hypertension
Weinman, E. J. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90287-8 · Cited by 10
Research works printed but not linked: 3
- Bursztyn M. Zelig O. Or R. Nagler, Isradipine for the prevention of cyclosporine-induced hpertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study, Transplantation, 63(7), 1034
- Golub, 1987, Direct augmentation by cyclosporine A of vascular contractile response to nerve stimulation, Hypertension, 9 (suppl 3), 96
- Hess, 1982, Effect of cyclosporine A on human lymphocyte response in vitro. III. CyA inhibits the production of T lymphocyte growth factors in secondary mixed-lymphocyte responses but does not inhibite the response of primed lymphocytes to TCGF., Immunol, 128, 355
Cited by
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Nast, A., Smith, C. H., Spuls, P. I., VALLE, G. L. A., Bata‐Csörgõ, Z., Boonen, H., de Jong, E. M. G. J., García-Doval, I., Gisondi, P., Kaur‐Knudsen, D., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16926 · Cited by 243
Beyond neurotransmission: acetylcholine in immunity and inflammation
Cox, M. A., Bassi, C., Saunders, M. E., Nechanitzky, R., Morgado‐Palacin, I., Zheng, C., & Mak, T. W. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13006 · Cited by 189
Psoriasis and comorbidities: links and risks
Chiu, M. W., & Ni, C. S. (2014) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s44843 · Cited by 156
Nystoriak, M. A., Nieves‐Cintrón, M., Nygren, P. J., Hinke, S. A., Nichols, C. B., Chen, C.-Y., Puglisi, J. L., Izu, L. T., Bers, D. M., Dell’Acqua, M. L., et al. (2013) · Circulation Research · doi:10.1161/circresaha.114.302168 · Cited by 107
Metadata
- Authors
- Robert, N., Wong, G. W., & Wright, J. M.
- Affiliations
- University of Basel (CH)
- University of British Columbia (CA)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2009-07-08
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4234247981
- Cited by
- 44
- References
- 7
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 6 · 2013: 3 · 2012: 2
- Type
- reference entry
- Language
- en
- Update notices
- new_version (2010-01-20)
- Open access
- closed
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- cyclosporine, blood pressure, antihypertensive effect, drug-induced hypertension, immunosuppressants, placebo comparison
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of cyclosporine on blood pressure. https://app.cochat.ai/papers/10.1002/14651858.cd007893
- The paper
- Robert, N., Wong, G. W., & Wright, J. M. (2009). Effect of cyclosporine on blood pressure. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd007893
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
